Yang Xiaohuang, Chen Shaoxing, Zhong Canmei, Lai Yadong, Chen Fenglin
Department of Gastroenterology and Fujian Institute of Digestive Disease, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
Department of Gastroenterology, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, Fujian, China.
PLoS One. 2025 Sep 12;20(9):e0331506. doi: 10.1371/journal.pone.0331506. eCollection 2025.
Gastric cancer is a serious health threat to people in Taiwan. This study reports gastric cancer burden and trends in Taiwan, from 1990 to 2021, and projects the incidence and mortality trends through 2036.
Data on gastric cancer burden in Taiwan came from the 2021 GBD database. Trend changes were evaluated via joinpoint analysis, with the Age-Period-Cohort model estimating age, period, and cohort influences. Decomposition analysis measured contributions of population growth, aging, and epidemiological factors, and the BAPC model forecast future burden.
Between 1990 and 2021, the age-standardized incidence rate (ASIR), age-standardized prevalence rate (ASPR), age-standardized mortality rate (ASMR), and age-standardized disability-adjusted life-year (DALY) rate (ASDR) of gastric cancer in Taiwan all showed a decreasing trend. In terms of absolute burden, the number of incident cases in 2021 was 4,839 (95% uncertainty interval [UI]: 4,272-5,352), representing a 41.20% increase, prevalent cases reached 9,835 (95% UI: 8,664-11,032), a 60.36% rise, deaths totaled 3,799 (95% UI: 3,345-4,220), up by 29.17%, and DALYs were 79,425 (95% UI: 71,168-87,813), with a 0.19% decrease. A significant gender disparity was observed, with males bearing a heavier burden. Projections indicate that incident cases and deaths will continue to rise through 2036.
Across the past 32 years, gastric cancer in Taiwan has exhibited a declining relative burden, yet the absolute burden has risen consistently and is forecast to keep increasing over the next 15 years. Precision risk control measures and context-specific public health policies are required to alleviate this burden.
胃癌对台湾民众的健康构成严重威胁。本研究报告了1990年至2021年台湾地区胃癌负担及趋势,并预测了到2036年的发病率和死亡率趋势。
台湾地区胃癌负担数据来自2021年全球疾病负担(GBD)数据库。通过连接点分析评估趋势变化,采用年龄-时期-队列模型估计年龄、时期和队列的影响。分解分析衡量人口增长、老龄化和流行病学因素的贡献,BAPC模型预测未来负担。
1990年至2021年期间,台湾地区胃癌的年龄标准化发病率(ASIR)、年龄标准化患病率(ASPR)、年龄标准化死亡率(ASMR)和年龄标准化伤残调整生命年(DALY)率(ASDR)均呈下降趋势。就绝对负担而言,2021年新发病例数为4839例(95%不确定区间[UI]:4272 - 5352),增长了41.20%;现患病例数达9835例(95% UI:8664 - 11032),增长了60.36%;死亡总数为3799例(95% UI:3345 - 4220),增长了29.17%;DALYs为79425(95% UI:71168 - 87813),下降了0.19%。观察到显著的性别差异,男性负担更重。预测表明,到2036年新发病例数和死亡数将持续上升。
在过去32年里,台湾地区胃癌的相对负担呈下降趋势,但绝对负担持续上升,预计未来15年还将继续增加。需要精准的风险控制措施和因地制宜的公共卫生政策来减轻这一负担。